EUVIMEDSkopri EUVIMED
Crossref

Downregulation of microRNA ‐326 enhances ZNF322A expression, transcriptional activity and tumorigenic effects in lung cancer

Shih-Hsuan Huang, Hung-Chia Hsieh, Jiunn-Min Shieh, Wou-Chou Su, Yi-Ching Wang iD

BioFactors · 2024

DOI: 10.1002/biof.2004 ↗

At a glance

Journal article in BioFactors, 2024. Written by Shih-Hsuan Huang and 4 co-authors. Institution: Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs. Cited 1 times so far (Crossref); 33 references. Funded by: Taiwan Ministry of Science and Technology.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Zinc finger protein ZNF322A is an oncogenic transcription factor. Overexpression of ZNF322A activates pro‐metastasis, cancer stemness, and neo‐angiogenesis‐related genes to enhance lung cancer progression. However, the upstream regulator of ZNF322A is not well defined. Dysregulation of microRNAs (miRNAs) can mediate cancer cell growth, migration, and invasion to promote tumorigenesis. Here, we uncover the mechanism of miRNA‐mediated transcriptional regulation in ZNF322A‐driven oncogenic events. ZNF322A harbors several putative miRNA‐binding sites in the 3′‐untranslated region (UTR). We validated that miR‐326 downregulated ZNF322A ‐3′‐UTR luciferase activity and mRNA expression. Furthermore, miR‐326 suppressed the expression of ZNF322A‐driven cancer‐associated genes such as cyclin D1 and alpha‐adducin . Reconstitution experiments by ectopic overexpression of ZNF322A abolished miR‐326‐suppressed cancer cell proliferation and cell migration capacity. Moreover, miR‐326 attenuated ZNF322A‐induced tumor growth and lung tumor metastasis in vivo. Clinically, the expression of miR‐326 negatively correlated with ZNF322A mRNA expression in surgically resected tissues from 120 non‐small cell lung cancer (NSCLC) patients. Multivariate Cox regression analysis demonstrated that NSCLC patients with low miR‐326/high ZNF322A profile showed poor overall survival. Our results reveal that the deregulated expression of miR‐326 leads to hyperactivation of ZNF322A‐driven oncogenic signaling. Targeting the miR‐326/ZNF322A axis would provide new therapeutic strategies for lung cancer patients.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsHumansCarcinogenesisCell Line, TumorCell MovementCell ProliferationDown-RegulationGene Expression Regulation, NeoplasticRNA, MessengerTranscription FactorsOncogene Proteins

Author keywords

ZNF322Alung cancermiR-326prognosistranscription

Substances

MicroRNAsRNA, MessengerMIRN326 microRNA, humanZNF322 protein, humanTranscription FactorsOncogene Proteins

Authors and institutions

  • Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Division of Chest Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • The Center of General Education, Chia Nan University of Pharmacy & Science, Tainan, Taiwan.
  • Division of Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

ORCID profiles: Yi-Ching Wang

Funding

  • Taiwan Ministry of Science and Technology

Cite

APA

Huang, S. H., Hsieh, H. C., Shieh, J. M., Su, W. C., & Wang, Y. C. (2024). Downregulation of microRNA ‐326 enhances ZNF322A expression, transcriptional activity and tumorigenic effects in lung cancer. BioFactors. https://doi.org/10.1002/biof.2004

Vancouver

Huang SH, Hsieh HC, Shieh JM, Su WC, Wang YC. Downregulation of microRNA ‐326 enhances ZNF322A expression, transcriptional activity and tumorigenic effects in lung cancer. BioFactors. 2024. doi:10.1002/biof.2004

BibTeX
@article{Huang2024,
  author = {Huang, Shih-Hsuan and Hsieh, Hung-Chia and Shieh, Jiunn-Min and Su, Wou-Chou and Wang, Yi-Ching},
  title = {Downregulation of microRNA ‐326 enhances ZNF322A expression, transcriptional activity and tumorigenic effects in lung cancer},
  journal = {BioFactors},
  year = {2024},
  doi = {10.1002/biof.2004}
}
Start for free →